Thus, in consideration of survivin's recognized role as a guardian of tumor cell survival, our results suggest that celecoxib and DMC might exert their cytotoxic anti-tumor effects at least in part via the down-regulation of survivin. This evidence concerns the gene BIRC5 and neoplasm.